Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 13.3% – Time to Sell?

Shares of Universe Pharmaceuticals INC (NYSE:UPC) fell 13.3% during mid-day trading on Friday . The company traded as low as $0.12 and last traded at $0.14. 2,142,620 shares changed hands during mid-day trading, an increase of 89% from the average session volume of 1,136,569 shares. The stock had previously closed at $0.16.

Universe Pharmaceuticals Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.63 and a quick ratio of 1.46. The firm has a 50 day moving average price of $7.15 and a 200-day moving average price of $31.57.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new position in shares of Universe Pharmaceuticals INC (NYSE:UPC) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned about 6.46% of Universe Pharmaceuticals at the end of the most recent quarter. Institutional investors and hedge funds own 0.18% of the company’s stock.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.